Literature DB >> 24411483

Apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging.

Florence F Roussotte1, Boris A Gutman2, Sarah K Madsen2, John B Colby1, Katherine L Narr1, Paul M Thompson3.   

Abstract

The apolipoprotein E epsilon 4 allele (ApoE-ε4) is the strongest known genetic risk factor for late onset Alzheimer's disease. Expansion of the lateral ventricles occurs with normal aging, but dementia accelerates this process. Brain structure and function depend on ApoE genotype not just for Alzheimer's disease patients but also in healthy elderly individuals, and even in asymptomatic young individuals. Therefore, we hypothesized that the ApoE-ε4 allele is associated with altered patterns of longitudinal ventricular expansion, in dementia and normal aging. We tested this hypothesis in a large sample of elderly participants, using a linear discriminant analysis-based approach. Carrying more ApoE-ε4 alleles was associated with faster ventricular expansion bilaterally and with regional patterns of lateral ventricle morphology at 1- and 2-year follow up, after controlling for sex, age, and dementia status. ApoE genotyping is considered critical in clinical trials of Alzheimer's disease. These findings, combined with earlier investigations showing that ApoE is also directly implicated in other conditions, suggest that the selective enrollment of ApoE-ε4 carriers may empower clinical trials of other neurological disorders.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ApoE; Dementia; Neuroimaging genetics; Structural MRI; Ventricular expansion

Mesh:

Substances:

Year:  2013        PMID: 24411483      PMCID: PMC3961511          DOI: 10.1016/j.neurobiolaging.2013.11.030

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  57 in total

Review 1.  Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

Authors:  Paul S Aisen; Ronald C Petersen; Michael C Donohue; Anthony Gamst; Rema Raman; Ronald G Thomas; Sarah Walter; John Q Trojanowski; Leslie M Shaw; Laurel A Beckett; Clifford R Jack; William Jagust; Arthur W Toga; Andrew J Saykin; John C Morris; Robert C Green; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia.

Authors:  Owen T Carmichael; Lewis H Kuller; Oscar L Lopez; Paul M Thompson; Rebecca A Dutton; Allen Lu; Sharon E Lee; Jessica Y Lee; Howard J Aizenstein; Carolyn C Meltzer; Yanxi Liu; Arthur W Toga; James T Becker
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Jan-Mar       Impact factor: 2.703

3.  APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients.

Authors:  Dimitrios Adamis; Adrian Treloar; Finbarr C Martin; Norman Gregson; Gillian Hamilton; Alastair J D Macdonald
Journal:  Int J Geriatr Psychiatry       Date:  2007-07       Impact factor: 3.485

Review 4.  Mild cognitive impairment: hope for stability, plan for progression.

Authors:  Birju B Patel; N Wilson Holland
Journal:  Cleve Clin J Med       Date:  2012-12       Impact factor: 2.321

5.  Hippocampal sulcal cavities on MRI: relationship to age and apolipoprotein E genotype.

Authors:  D P Barboriak; P M Doraiswamy; K R Krishnan; S Vidyarthi; J Sylvester; H C Charles
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

6.  ApoE genotype and survival from intracerebral haemorrhage.

Authors:  M J Alberts; C Graffagnino; C McClenny; D DeLong; W Strittmatter; A M Saunders; A D Roses
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

Review 7.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

8.  Apolipoprotein E polymorphism, homocysteine serum levels and hippocampal volume in patients with alcoholism: an investigation of a gene-environment interaction.

Authors:  J Wilhelm; H Frieling; N von Ahsen; T Hillemacher; J Kornhuber; S Bleich
Journal:  Pharmacogenomics J       Date:  2007-04-10       Impact factor: 3.550

9.  Apolipoprotein E epsilon 4 is associated with hippocampal volume reduction in females with alcoholism.

Authors:  S Bleich; J Wilhelm; E Graesel; D Degner; W Sperling; V Rössner; K Javaheripour; J Kornhuber
Journal:  J Neural Transm (Vienna)       Date:  2003-04       Impact factor: 3.575

10.  Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.

Authors:  Kewei Chen; Eric M Reiman; Gene E Alexander; Richard J Caselli; Richard Gerkin; Daniel Bandy; Alisa Domb; David Osborne; Nick Fox; William R Crum; Ann M Saunders; John Hardy
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

View more
  11 in total

Review 1.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

Review 2.  Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.

Authors:  Marine Fouquet; Florent L Besson; Julie Gonneaud; Renaud La Joie; Gaël Chételat
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

3.  Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype.

Authors:  Shruti Mishra; Tyler M Blazey; David M Holtzman; Carlos Cruchaga; Yi Su; John C Morris; Tammie L S Benzinger; Brian A Gordon
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

4.  Differential 5-year brain atrophy rates in cognitively declining and stable APOE-ε4 elders.

Authors:  Dana A Kelly; Michael Seidenberg; Katherine Reiter; Kristy A Nielson; John L Woodard; J Carson Smith; Sally Durgerian; Stephen M Rao
Journal:  Neuropsychology       Date:  2018-06-18       Impact factor: 3.295

5.  The impact of Alzheimer's disease susceptibility loci on lateral ventricular surface morphology in older adults.

Authors:  Shan Li; Na An; Nan Chen; Yin Wang; Lin Yang; Yalin Wang; Zhijun Yao; Bin Hu
Journal:  Brain Struct Funct       Date:  2022-01-14       Impact factor: 3.270

6.  Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.

Authors:  Florence F Roussotte; Boris A Gutman; Sarah K Madsen; John B Colby; Paul M Thompson
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

Review 7.  A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.

Authors:  Emma Lawrence; Carolin Vegvari; Alison Ower; Christoforos Hadjichrysanthou; Frank De Wolf; Roy M Anderson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Applying surface-based morphometry to study ventricular abnormalities of cognitively unimpaired subjects prior to clinically significant memory decline.

Authors:  Qunxi Dong; Wen Zhang; Cynthia M Stonnington; Jianfeng Wu; Boris A Gutman; Kewei Chen; Yi Su; Leslie C Baxter; Paul M Thompson; Eric M Reiman; Richard J Caselli; Yalin Wang
Journal:  Neuroimage Clin       Date:  2020-07-05       Impact factor: 4.881

9.  The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Jingfen Zhu; Rong Shi; Su Chen; Lihua Dai; Tian Shen; Yi Feng; Pingping Gu; Mina Shariff; Tuong Nguyen; Yeats Ye; Jianyu Rao; Guoqiang Xing
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-11       Impact factor: 2.629

10.  Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study.

Authors:  Bolun Li; Jie Shi; Boris A Gutman; Leslie C Baxter; Paul M Thompson; Richard J Caselli; Yalin Wang
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.